Press release
Acute Myocardial Infarction Market Trends, Size, Share & Forecast 2025 | Top key players - Bayer AG, AstraZeneca, Pfizer Inc.
Acute Myocardial Infarction Market
The Global Acute Myocardial Infarction Market reached US$ 1,790.79 million in 2024 and is expected to reach US$ 3,065.81 million by 2033, growing at a CAGR of 6.7 % during the forecast period of 2025-2033.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID) @ https://datamintelligence.com/download-sample/acute-myocardial-infarction-market?sz
The Acute Myocardial Infarction (AMI) market refers to the healthcare industry segment focused on diagnosing, treating, and managing heart attacks. It includes medications, devices, and therapies aimed at restoring blood flow, minimizing heart damage, and improving patient outcomes. This market is driven by rising cardiovascular disease rates, aging populations, and advances in emergency cardiac care and intervention technologies.
Major players in the Acute Myocardial Infarction Market
The prominent players in Acute Myocardial Infarction market research report are: AGEPHA Pharma FZ-LLC, Genentech, Inc., Sanofi, Boehringer Ingelheim International GmbH. (Eli Lilly and Company), Bayer AG, Daiichi Sankyo Company, Limited, AstraZeneca, Pfizer Inc., Fresenius Kabi, Viatris Inc. (Idorsia) and among others.
The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.
Key Development
In February 2024, global biotechnology leader CSL announced the top-line results from its Phase 3 AEGIS-II trial, which evaluated the efficacy and safety of CSL112 (apolipoprotein A-I [human]) in lowering major adverse cardiovascular events (MACE) in patients following an acute myocardial infarction (AMI). While the trial did not meet its primary efficacy endpoint of reducing MACE at 90 days, it reported no major safety or tolerability issues with CSL112. As a result, CSL has stated that it has no immediate plans to pursue regulatory approval.
Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/acute-myocardial-infarction-market
Market Segments
By Treatment Type: Colchicine, Tenecteplase, Empagliflozin, Antiplatelet Agents, Anticoagulants, Glycoprotein IIb/IIIa inhibitor, Antianginal therapy, Beta-blocker, ACE inhibitor, Statin, Devices, Others.
By Route of Administration: Oral, Intravenous (IV), Others.
The Acute Myocardial Infarction industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.
Regions Covered:
The global Acute Myocardial Infarction Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acute Myocardial Infarction Market Trends, Size, Share & Forecast 2025 | Top key players - Bayer AG, AstraZeneca, Pfizer Inc. here
News-ID: 4017086 • Views: …
More Releases from DataM Intelligence 4Market Research
Ultrasonography Market is expected to reach US$ 15.66 billion by 2033 | Major ke …
Market Size and Growth:
The Global Ultrasonography Market size reached US$ 8.27 billion in 2024 and is expected to reach US$ 15.66 billion by 2033, growing at a CAGR of 6.6 % during the forecast period 2025-2033.
The Ultrasonography Market encompasses products, technologies, and services used to generate real-time images of internal body structures using high-frequency sound waves. It includes diagnostic ultrasound systems, portable and point-of-care devices, transducers, and related software across…
Ankle Braces Market is expected to reach US$ 4.68 billion by 2033 | Major key pl …
Market Size and Growth:
The Global Ankle Braces Market size reached US$ 2.60 billion in 2024 and is expected to reach US$ 4.68 billion by 2033, growing at a CAGR of 6.8% during the forecast period 2025-2033.
The Ankle Braces Market refers to the global industry involved in the development, manufacturing, and distribution of orthopedic devices designed to support, stabilize, and protect the ankle joint. These braces are commonly used for injury…
Sterilization Services Market is expected to reach US$8.77 billion by 2033 | Maj …
Market Size and Growth:
The Global Sterilization Services Market size reached US$ 4.50 billion in 2024 and is expected to reach US$ 8.77 billion by 2033, growing at a CAGR of 7.7% during the forecast period 2025-2033.
The Sterilization Services Market refers to the industry providing outsourced sterilization solutions to eliminate microorganisms from medical devices, pharmaceuticals, biologics, and healthcare products. These services use methods such as ethylene oxide, gamma irradiation, steam, and…
Ostomy Care Devices Market is expected to reach US$ 7.51 billion by 2033 | Emerg …
Market Size and Growth:
The Global Ostomy Care Devices Market size reached US$ 3.54 billion in 2024 and is expected to reach US$ 7.51 billion by 2033, growing at a CAGR of 7.8% during the forecast period 2025-2033.
The Ostomy Care Devices Market refers to the global industry focused on products designed to manage bodily waste through a surgically created opening (ostomy) in the abdomen. These devices include ostomy bags, skin barriers,…
More Releases for Acute
Acute Lymphoblastic Leukemia Therapeutics Market Size, Acute Lymphoblastic Leuke …
Acute Lymphoblastic Leukemia Therapeutics Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Acute Lymphoblastic Leukemia Therapeutics research data, benefit, gross margin,…
Acute Conjunctivitis Treatment Market: The Future Insights Of Global Acute Conju …
Acute Conjunctivitis Treatment Market
Acute Conjunctivitis Treatment Market, or pink eye, is an irritation or inflammation of the conjunctiva that covers the white part of the eyeball. It can be caused by allergies or a bacterial or viral infection. Acute Conjunctivitis Treatment Market can be highly communicable and can be spread easily by the contact with secretions of eye from the infected person. Conjunctivitis often resolves on its own, but…
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H …
ReportsWorldwide has announced the addition of a new report title Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials scenario. This report provides top line data relating to…
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical T …
ReportsWorldwide has announced the addition of a new report title Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical trials scenario. This report provides top line data relating to…
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Tri …
ReportsWorldwide has announced the addition of a new report title Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) clinical trials scenario. This report provides top line data relating to…
H2 2016 Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Therapeut …
Albany, New York, January 03, 2017: A recent forecast report focusing on the Acute Myelocytic Leukemia Market has been added to the wide portfolio of Market Research Hub (MRH). It is entitled as, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016” which has been equipped by in-depth market examination with inputs from the industry experts. It covers the current market scenario and also its future growth…
